NYTのチャート
NYTの企業情報
| symbol | NYT |
|---|---|
| 会社名 | New York Times Co. （NYT ニューヨーク・タイムズ） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 一般向け出版 サ―ビス（Services） |
| 概要 | 事業概要 ニューヨーク・タイムズ(The New York Times Company)は、ニュースと情報の作成・収集・配布に従事するメディア会社である。同社の主要事業は印刷物、ウェブ、モバイルプラットフォームを通じて、ニュースルームによって生成されたコンテンツの配信である。同社はまた選択したコンテンツをサードパーティのプラットフォームに配布する。同社には新聞、印刷物、デジタル製品、投資が含まれる。同社の事業には、The New York Times（The Times）などの新聞、 NYTimes.comを含むウェブサイト、The Timesニュースアプリケーションなどのモバイルアプリケーション、NYT Cooking、Crosswordなどのインタレスト・アプリケーション、The Timesニュースサービス部門、製品レビュー、The WirecutterとThe Sweethomeなどの推奨Webサイトなどの関連ビジネス、デジタル・アーカイブ配信、NYT Live（ライブイベント事業）、「The Times」というブランドでの他の製品やサービスを含む。 ニューヨーク・タイムズは米国の大手メディア企業。新聞｢ニューヨーク・タイムズ｣と｢ニューヨーク・タイムズ・インタ―ナショナル｣を発行するほか、パソコンやスマ―トフォンでの購読が可能なオンライン版｢NYTimes.com｣と｢international.nytimes.com｣を運営する。 The New York Times Company is a global media organization dedicated to enhancing society by creating, collecting and distributing high-quality news and information. The Company includes The New York Times, NYTimes.com and related properties. It is known globally for excellence in its journalism, and innovation in its print and digital storytelling and its business model. |
| 本社所在地 | 620 Eighth Avenue New York NY 10018 USA |
| 代表者氏名 | Mark Thompson |
| 代表者役職名 | President Chief Executive Officer Director |
| 電話番号 | +1 212-556-1234 |
| 設立年月日 | 1896年8月 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 4320人 |
| url | www.nytco.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 255.56700 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 5451.30300 |
| 売上高 | 売上高（百万ドル） 1748.59800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 5092.12800 |
| 当期純利益 | 当期純利益（百万ドル） 123.81200 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 30 December 2018 New York Times Co revenues increased 4% to $1.75B. Net income before extraordinary items increased 69% to $123.8M. Revenues reflect Other increase of 36% to $147.8M Subscription increase of 3% to $1.04B. Net income benefited from Other Non Operating I/E decrease of 87% to $8.3M (expense) Severance decrease of 72% to $6.7M (expense). |
NYTのテクニカル分析
NYTのニュース
New York Times Company (The) – Consensus Indicates Potential -14.7% Downside 2023/02/10 12:36:40 DirectorsTalk
This article New York Times Company (The) – Consensus Indicates Potential -14.7% Downside first appeared on DirectorsTalk Interviews .
7 Stocks to Watch if You’re Looking for the Next High Flyer 2023/02/10 00:53:16 InvestorPlace
While volatility persists, markets have managed to get off to a strong start in 2023 . All three of the major U.S. stock indices are positive on the year, with the technology-laden Nasdaq leading the pack with a 14% year-to-date gain. However, a rising tide has not lifted all boats, at least not yet. Some stocks to watch are up nearly 30% since the start of January. Others stocks continue the downward trend they endured last year. This environment requires investors to choose the stocks they buy carefully, separating the wheat from the chaff. Earnings continue to drive share prices higher or lower, as does the macroeconomic environment and lingering fears of a global recession at some point this year. As always, investors will have to do their homework to find winning equities. Here are seven stocks to watch if you’re looking for the next high flyer. NYT The New York Times $40.12 UFPT UFP Technologies $109.35 AMD Advanced Micro Devices $83.21 ODFL Old Dominion Freight Line $355.00 PII Polaris $115.00 CMG Chipotle Mexican Grill $1,606.91 RACE Ferrari $266.31 The New York Times (NYT) Source: pio3 / Shutterstock.com First up on my list of stocks to watch is The New York Times (NYSE: NYT ), which is up 24% so far in 2023 following strong fourth-quarter and full-year 2022 earnings .
Benzinga''s Top Ratings Upgrades, Downgrades For February 9, 2023 2023/02/09 15:00:38 Benzinga
Upgrades For EMCORE Corp (NASDAQ: EMKR ), Lake Street upgraded the previous rating of Hold to Buy. For the first quarter, EMCORE had an EPS of $0.22, compared to year-ago quarter EPS of $0.14. The current stock performance of EMCORE shows a 52-week-high of $5.94 and a 52-week-low of $0.86. Moreover, at the end of the last trading period, the closing price was at $1.32. Craig-Hallum upgraded the previous rating for Cerence Inc (NASDAQ: CRNC ) from Hold to Buy. For the first quarter, Cerence had an EPS of $0.36, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $47.80 and a 52-week-low of $12.82. At the end of the last trading period, Cerence closed at $28.92. For Kiora Pharmaceuticals Inc (NASDAQ: KPRX ), Maxim Group upgraded the previous rating of Hold to Buy. For the third quarter, Kiora Pharmaceuticals had an EPS of $4.35, compared to year-ago quarter EPS of $11.60. The stock has a 52-week-high of $39.18 and a 52-week-low of $2.32. At the end of the last trading period, Kiora Pharmaceuticals closed at $6.94.
New York Times Q4 Earnings: 12% Sales Growth, Subscriber Additions, 22% Dividend Boost And $250M Buyback 2023/02/08 19:32:38 Benzinga
New York Times Co (NYSE: NYT ) reported fourth-quarter FY22 sales growth of 12.3% year-on-year, to $667.54 million, beating the consensus of $646.44 million . Revenue from Subscriptions rose 17.9%, and Advertising grew 1.4%. Digital-only subscription revenue increased 31% Y/Y to $269.2 million. Digital advertising revenue rose 0.6% to $111.9 million. Total operating cost increased by … Full story available on Benzinga.com
New York Times Company (The) – Consensus Indicates Potential -14.7% Downside 2023/02/10 12:36:40 DirectorsTalk
This article New York Times Company (The) – Consensus Indicates Potential -14.7% Downside first appeared on DirectorsTalk Interviews .
7 Stocks to Watch if You’re Looking for the Next High Flyer 2023/02/10 00:53:16 InvestorPlace
While volatility persists, markets have managed to get off to a strong start in 2023 . All three of the major U.S. stock indices are positive on the year, with the technology-laden Nasdaq leading the pack with a 14% year-to-date gain. However, a rising tide has not lifted all boats, at least not yet. Some stocks to watch are up nearly 30% since the start of January. Others stocks continue the downward trend they endured last year. This environment requires investors to choose the stocks they buy carefully, separating the wheat from the chaff. Earnings continue to drive share prices higher or lower, as does the macroeconomic environment and lingering fears of a global recession at some point this year. As always, investors will have to do their homework to find winning equities. Here are seven stocks to watch if you’re looking for the next high flyer. NYT The New York Times $40.12 UFPT UFP Technologies $109.35 AMD Advanced Micro Devices $83.21 ODFL Old Dominion Freight Line $355.00 PII Polaris $115.00 CMG Chipotle Mexican Grill $1,606.91 RACE Ferrari $266.31 The New York Times (NYT) Source: pio3 / Shutterstock.com First up on my list of stocks to watch is The New York Times (NYSE: NYT ), which is up 24% so far in 2023 following strong fourth-quarter and full-year 2022 earnings .
Benzinga''s Top Ratings Upgrades, Downgrades For February 9, 2023 2023/02/09 15:00:38 Benzinga
Upgrades For EMCORE Corp (NASDAQ: EMKR ), Lake Street upgraded the previous rating of Hold to Buy. For the first quarter, EMCORE had an EPS of $0.22, compared to year-ago quarter EPS of $0.14. The current stock performance of EMCORE shows a 52-week-high of $5.94 and a 52-week-low of $0.86. Moreover, at the end of the last trading period, the closing price was at $1.32. Craig-Hallum upgraded the previous rating for Cerence Inc (NASDAQ: CRNC ) from Hold to Buy. For the first quarter, Cerence had an EPS of $0.36, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $47.80 and a 52-week-low of $12.82. At the end of the last trading period, Cerence closed at $28.92. For Kiora Pharmaceuticals Inc (NASDAQ: KPRX ), Maxim Group upgraded the previous rating of Hold to Buy. For the third quarter, Kiora Pharmaceuticals had an EPS of $4.35, compared to year-ago quarter EPS of $11.60. The stock has a 52-week-high of $39.18 and a 52-week-low of $2.32. At the end of the last trading period, Kiora Pharmaceuticals closed at $6.94.
New York Times Q4 Earnings: 12% Sales Growth, Subscriber Additions, 22% Dividend Boost And $250M Buyback 2023/02/08 19:32:38 Benzinga
New York Times Co (NYSE: NYT ) reported fourth-quarter FY22 sales growth of 12.3% year-on-year, to $667.54 million, beating the consensus of $646.44 million . Revenue from Subscriptions rose 17.9%, and Advertising grew 1.4%. Digital-only subscription revenue increased 31% Y/Y to $269.2 million. Digital advertising revenue rose 0.6% to $111.9 million. Total operating cost increased by … Full story available on Benzinga.com
New York Times Q4 Earnings: 12% Sales Growth, Subscriber Additions, 22% Dividend Boost And $250M Buyback 2023/02/08 19:32:38 Benzinga
New York Times Co (NYSE: NYT ) reported fourth-quarter FY22 sales growth of 12.3% year-on-year, to $667.54 million, beating the consensus of $646.44 million . Revenue from Subscriptions rose 17.9%, and Advertising grew 1.4%. Digital-only subscription revenue increased 31% Y/Y to $269.2 million. Digital advertising revenue rose 0.6% to $111.9 million. Total operating cost increased by … Full story available on Benzinga.com
New York Times Co (NYT) Q4 2022 Earnings Call Transcript 2023/02/08 18:10:34 Seeking Alpha
New York Times Co (NYSE:NYSE:NYT) Q4 2022 Earnings Conference Call February 8, 2023 8:00 AM ETCompany ParticipantsHarlan Toplitzky - Executive Director, IR and Financial Planning &…
The New York Times Co., Q4 Profit Increases, beats estimates 2023/02/08 12:36:00 Finanz Nachrichten
WASHINGTON (dpa-AFX) - The New York Times Co., (NYT) revealed earnings for its fourth quarter that increased from the same period last year and beat the Street estimates.The company''s bottom line …